PRESS RELEASE: CMS assigns new technology payment classification for Optellum’s Lung Cancer Prediction score

This payment assignment to a newly available Healthcare Common Procedure Coding System (HCPCS) code constitutes an important step towards reimbursing providers for the use of Optellum’s transformative technology with Medicare…

Continue ReadingPRESS RELEASE: CMS assigns new technology payment classification for Optellum’s Lung Cancer Prediction score

Optellum’s UK regulatory certification bolstered by UKCA marking for its early lung cancer diagnosis AI technology

After gaining CE certification for its software Virtual Nodule Clinic, Optellum has attained UKCA certification under the UK’s Medical Devices Regulations. Optellum, an Oxford-based medtech company, provides breakthrough AI technologies…

Continue ReadingOptellum’s UK regulatory certification bolstered by UKCA marking for its early lung cancer diagnosis AI technology

PRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation. Oxford, UK – 30 March 2022:…

Continue ReadingPRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Optellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

Optellum is referenced within the report with recommendations on how AI will be implemented and physicians trained in new technologies across the NHS Optellum has been named as one of…

Continue ReadingOptellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report